Evidence map›Paper›PMID 29301856›Full record

ArticleEMBO reports2018

Rad9/53BP1 protects stalled replication forks from degradation in Mec1/ATR-defective cells.

Matteo Villa, Diego Bonetti, Massimo Carraro, Maria Pia Longhese

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matteo VillaDipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Milan, Italy.
Diego BonettiDipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Milan, Italy.
Massimo CarraroDipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Milan, Italy.
Maria Pia LongheseDipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Milan, Italy mariapia.longhese@unimib.it.ORCID 0000-0003-1726-2034
University of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleolytic processing by nucleases can be a relevant mechanism to allow repair/restart of stalled replication forks. However, nuclease action needs to be controlled to prevent overprocessing of damaged replication forks that can be detrimental to genome stability. The checkpoint protein Rad9/53BP1 is known to limit nucleolytic degradation (resection) of DNA double-strand breaks (DSBs) in both yeast and mammals. Here, we show that loss of the inhibition that Rad9 exerts on resection exacerbates the sensitivity to replication stress of Mec1/ATR-defective yeast cells by exposing stalled replication forks to Dna2-dependent degradation. This Rad9 protective function is independent of checkpoint activation and relies mainly on Rad9-Dpb11 interaction. We propose that Rad9/53BP1 supports cell viability by protecting stalled replication forks from extensive resection when the intra-S checkpoint is not fully functional.

Indexed as

DNA ReplicationCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsMicrobial ViabilityProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsStress, PhysiologicalTumor Suppressor p53-Binding Protein 1Cell Cycle ProteinsIntracellular Signaling Peptides and ProteinsMEC1 protein, S cerevisiaeProtein Serine-Threonine Kinasesrad9 proteinSaccharomyces cerevisiae ProteinsTumor Suppressor p53-Binding Protein 1Mec1Rad9replication forksresectionSgs1

Identifiers

PMID29301856
PMCPMC5797966
OpenAlexW2782108848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.